# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The financial statement impact of the Government Services business process, and any resulting loss or gain, is uncertain at thi...
As part of the agreement, approximately 950 employees will join CorroHealth. The transaction is expected to close by the end of...
- Bloomberg
Keefe, Bruyette & Woods analyst Sanjay Sakhrani maintains Navient (NASDAQ:NAVI) with a Market Perform and raises the pri...
Navient (NASDAQ:NAVI) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.43 by 32...
A federal appeals court has blocked President Joe Biden's administration from implementing its Saving on a Valuable Educati...
Barclays analyst Terry Ma maintains Navient (NASDAQ:NAVI) with a Underweight and lowers the price target from $11 to $10.